@article{c8b92ec37dc64087b862391da28f2163,
title = "Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis",
abstract = "Purpose: To conduct a pooled analysis assessing the association of blood transfusion with risk of non-Hodgkin lymphoma (NHL). Methods: We used harmonized data from 13 case–control studies (10,805 cases, 14,026 controls) in the InterLymph Consortium. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, adjusted for study design variables. Results: Among non-Hispanic whites (NHW), history of any transfusion was inversely associated with NHL risk for men (OR 0.74; 95% CI 0.65–0.83) but not women (OR 0.92; 95% CI 0.83–1.03), pheterogeneity = 0.014. Transfusion history was not associated with risk in other racial/ethnic groups. There was no trend with the number of transfusions, time since first transfusion, age at first transfusion, or decade of first transfusion, and further adjustment for socioeconomic status, body mass index, smoking, alcohol use, and HCV seropositivity did not alter the results. Associations for NHW men were stronger in hospital-based (OR 0.56; 95% CI 0.45–0.70) but still apparent in population-based (OR 0.84; 95% CI 0.72–0.98) studies. Conclusions: In the setting of a literature reporting mainly null and some positive associations, and the lack of a clear methodologic explanation for our inverse association restricted to NHW men, the current body of evidence suggests that there is no association of blood transfusion with risk of NHL.",
keywords = "Epidemiology, Etiology, Lymphoma, Pooled analysis, Transfusion",
author = "Cerhan, {James R.} and Eleanor Kane and Vajdic, {Claire M.} and Linet, {Martha S.} and Alain Monnereau and Leslie Bernstein and {de Sanjose}, Silvia and Chiu, {Brian C.H.} and Spinelli, {John J.} and Maso, {Luigino Dal} and Yawei Zhang and Larrabee, {Beth R.} and Wendy Cozen and Smith, {Alexandra G.} and Jacqueline Clavel and Diego Serraino and Tongzhang Zheng and Holly, {Elizabeth A.} and Weisenberger, {Dennis D.} and Slager, {Susan L.} and Bracci, {Paige M.}",
note = "Funding Information: British Columbia study: Canadian Institutes for Health Research (CIHR), Canadian Cancer Society, and Michael Smith Foundation for Health Research; Engela study: Association pour la recherch{\'e} contre le Cancer, Institut National du Cancer, Fondation de France, Fondation contre la Leuc{\'e}mie, Agence nationale de s{\'e}curit{\'e} sanitaire de l{\textquoteright}alimentation, de l{\textquoteright}environnement et du travail (ANSES); EpiLymph: European Commission (QLK4-CT-2000-00422 and FOOD-CT-2006-023103), Spanish Ministry of Health (CIBERESP, PI11/01810, RCESP C03/09, RTICESP C03/10, and RTIC RD06/0020/0095), Rio Hortega (CM13/00232), Ag{\`e}ncia de Gesti{\'o} d{\textquoteright}Ajuts Universitaris i de Recerca–Generalitat de Catalunya (Catalonian Government, 2009SGR1026), National Institutes of Health (contract NO1-CO-12400), Italian Ministry of Education, University and Research (PRIN 2007 prot.2007WEJLZB, PRIN 2009 prot. 20092ZELR2), Italian Association for Cancer Research (IG grant 11855/2011), Federal Office for Radiation Protection (StSch4261 and StSch4420), Jos{\'e} Carreras Leukemia Foundation (DJCLS-R04/08), German Federal Ministry for Education and Research (BMBF-01-EO-1303), Health Research Board, Ireland and Cancer Research Ireland, and Czech Republic MH CZ—DRO (MMCI, 00209805); Iowa-Minnesota study: Intramural Research Program of the National Cancer Institute/National Institutes of Health; Aviano-Naples (Italy) study: Italian Association for Cancer Research (AIRC); Los Angeles study: National Cancer Institute/National Institutes of Health (R01 CA50850); Mayo Clinic study: National Cancer Institute/National Institutes of Health (R01 CA92153 and P50 CA97274), Lymphoma Research Foundation (164738), and the Henry J. Predolin Foundation; NCI-SEER study: Intramural Research Program of the National Cancer Institute/National Institutes of Health and Public Health Service (contracts N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, and N02-PC-71105); Nebraska study: American Institute for Cancer Research (99B083) and the National Cancer Institute (CA94770 and CA100555); Australian study: National Health and Medical Research Council, Australia (Grant number: 990920), the Cancer Council NSW, Australia, University of Sydney Faculty of Medicine; UCSF study: National Cancer Institute (R01 CA45614, R03 CA89745, R01 CA087014); UK study: Bloodwise (UK); and Yale study: National Cancer Institute/National Institutes of Health (CA62006 and CA165923). Acknowledgments Publisher Copyright: {\textcopyright} 2019, Springer Nature Switzerland AG.",
year = "2019",
month = aug,
day = "1",
doi = "10.1007/s10552-019-01188-w",
language = "English (US)",
volume = "30",
pages = "889--900",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "8",
}